In the United States alone, it is estimated that there will be over 138,000 new cases of colorectal cancer diagnosed and over 50,000 deaths in 2001. This represents the fourth most common malignancy and the second leading cause of cancer death. Surgery remains the mainstay of treatment for this disease. However, it is limited by tumour stage, location and biological behavior. Although curable in its early stages, the ultimate overall survival is no better than 50%. These numbers have remain relatively constant despite screening and attempts at earlier diagnosis. Newer advances in surgical therapy have centered on the management of rectal carcinoma. Laparoscopic surgical techniques have been adapted to surgical resection of the colon however for malignant processes it still remains investigational.
|Original language||English (US)|
|Number of pages||5|
|Journal||Annals of Gastroenterology|
|State||Published - Dec 1 2003|
ASJC Scopus subject areas